ID: ALA3823933

Max Phase: Preclinical

Molecular Formula: C21H42O4

Molecular Weight: 358.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCOC(=O)C[C@@H](OCCCCCCCC)[C@@H](C)O

Standard InChI:  InChI=1S/C21H42O4/c1-4-6-8-10-12-14-16-24-20(19(3)22)18-21(23)25-17-15-13-11-9-7-5-2/h19-20,22H,4-18H2,1-3H3/t19-,20-/m1/s1

Standard InChI Key:  HZMXLATWLRWNOV-WOJBJXKFSA-N

Associated Targets(non-human)

Prkcd Protein kinase C delta (192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.56Molecular Weight (Monoisotopic): 358.3083AlogP: 5.41#Rotatable Bonds: 18
Polar Surface Area: 55.76Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.98CX LogD: 5.98
Aromatic Rings: 0Heavy Atoms: 25QED Weighted: 0.26Np Likeness Score: 0.31

References

1. Ashida Y, Yanagita RC, Takahashi C, Kawanami Y, Irie K..  (2016)  Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.,  24  (18): [PMID:27436807] [10.1016/j.bmc.2016.07.011]

Source